INmune is a clinical-stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patients’ NK cells (natural killer cells) to kill cancer.

The company is also developing XPro, a therapy for dementia, including Alzheimer’s disease. XPro has shown promising results in clinical trials, helping the brain heal itself.